You, on the other hand, have had a debate in Washington which included only the last two options on the list.

FORBES: House GOP, You've Been Had

Two weeks into the April market, only one stock picker, the Options Tactician, still had 50% gains on his 11-week-old portfolio.

FORBES: Pick Of The Stock

Eastern, took the unusual step of printing not one but two editorials about the study, both recommending doctors only turn to Zetia and Vytorin after they had exhausted all other options.

FORBES: A Backlash Against Vytorin?